Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
Allogeneic transplant
Bone marrow transplant
Cancer
Cancer care
Hematopoietic stem cell transplantation
Post traumatic growth
Stem cell transplant
Survivors
Survivorship
Journal
BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676
Informations de publication
Date de publication:
16 Aug 2023
16 Aug 2023
Historique:
received:
20
10
2022
accepted:
09
05
2023
medline:
18
8
2023
pubmed:
17
8
2023
entrez:
16
8
2023
Statut:
epublish
Résumé
Given the increasing number of Hematopoietic Stem Cell Transplantations (HSCT) performed world-wide, the increasing likelihood of survival following HSCT, and the profound physical, psychosocial, and emotional impact of HSCT on survivors, their carers and families, it is important to identify factors that may contribute to or support post-traumatic growth (PTG) after transplant. In this study, we aimed to investigate the prevalence of PTG in an Australian cohort of long-term allogeneic HSCT survivors and describe associations between PTG and relevant clinical, sociodemographic and psychological variables. This was a large, multi-centre, cross sectional survey of Australian HSCT-survivors inviting all those transplanted in New South Wales between 2000 and 2012. Respondents completed the PTG Inventory (PTGI), the Sydney Post-BMT Survey, FACT-BMT, DASS 21, The Chronic Graft versus Host Disease (GVHD) Activity Assessment-Patient Self-Report (Form B), the Lee Chronic GVHD Symptom Scale, and the Fear of Cancer Recurrence Scale. Data was analysed using independent t-tests, one-way analysis of variance, and pearson's correlations, and hierarchical multiple regression adjusted for potential confounders and to ascertain independent associations of explanatory variables with PTG. Of 441 respondents, 99% reported some level of PTG with 67% reporting moderate to high levels of PTG. Female gender, younger age, complementary therapy use, anxiety, psychological distress and psychosocial care, and higher quality of life were associated with higher levels of PTG. Importantly, we also found that PTG was not associated with either chronic GVHD or post-HSCT morbidity. In this study - the largest study of PTG in long-term allogeneic HSCT survivors - we found that growth appears ubiquitous, with 99% of survivors reporting some degree of PTG and 67% reporting moderate-high levels of PTG. Importantly, we found no association with GVHD or chronic physical post-HSCT morbidity, or adverse financial, occupational or sexual impacts. This suggests that it is the necessity for and experience of, HSCT itself that foments personal growth. Accordingly, healthcare professionals should be alert to the profound and wide-ranging impact of HSCT - and the degree to which survivor's may experience PTG. Identifying interventions that may assist HSCT survivors cope and building their resilience is of utmost importance.
Identifiants
pubmed: 37587508
doi: 10.1186/s40359-023-01204-4
pii: 10.1186/s40359-023-01204-4
pmc: PMC10433676
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
235Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Australasian Bone Marrow Transplant Recipient Registry. Australasian Bone Marrow Transplant Recipient Registry: Annual Data Summary 2018. Australia: ABMTRR: NSW; 2019.
Passweg JR, Baldomero H, Chabannon C, et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant. 2020;55:1604–13. 2020/02/19.
doi: 10.1038/s41409-020-0826-4
pubmed: 32066864
pmcid: 7391287
Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. 2012;18:348–71. https://doi.org/10.1016/j.bbmt.2011.12.519 . Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. 2011/12/20.
doi: 10.1016/j.bbmt.2011.12.519
pubmed: 22178693
Australasian Bone Marrow Transplant Recipient Registry. Australasian Bone Marrow Transplant Recipient Registry: Annual Data Summary 2020. Australia: ABMTRR: NSW; 2021.
Alaloul F, Brockopp DY, Andrykowski MA, et al. Quality of life in arab muslim cancer survivors following hematopoietic stem cell transplantation: comparison with matched healthy group. Support Care in Cancer. 2015;23:2157–64. 2015/01/06.
doi: 10.1007/s00520-014-2583-7
Beattie S, Lebel S. The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review. Psycho-oncology. 2011;20:1137–50. 2011/03/23.
doi: 10.1002/pon.1962
pubmed: 21425389
Cheon J, Lee YJ, Jo JC, et al. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2021;29:975–86. 2020/06/20.
doi: 10.1007/s00520-020-05572-0
pubmed: 32556712
Esser P, Kuba K, Scherwath A, et al. Posttraumatic stress disorder symptomatology in the course of allogeneic HSCT: a prospective study. J Cancer Surviv. 2017;11:203–210. 2016/11/01. https://doi.org/10.1007/s11764-016-0579-7 .
doi: 10.1007/s11764-016-0579-7
pubmed: 27796710
Sun CL, Kersey JH, Francisco L, et al. Burden of morbidity in 10 + year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant. 2013;19:1073–80. 2013/04/16.
doi: 10.1016/j.bbmt.2013.04.002
pubmed: 23583827
pmcid: 3691346
Corman M, Rubio MT, Cabrespine A, et al. Retrospective and prospective measures of post-traumatic growth reflect different processes: longitudinal evidence of greater decline than growth following a hematopoietic stem-cell transplantation. BMC Psychiatry. 2021;21:27. 2021/01/13.
doi: 10.1186/s12888-020-03007-y
pubmed: 33430807
pmcid: 7798346
Tallman B, Shaw K, Schultz J, et al. Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: a nine-year longitudinal study. Rehabil Psychol. 2010;55:204. 210.2010/05/26. https://doi.org/10.1037/a0019541
doi: 10.1037/a0019541
pubmed: 20496975
Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455–71. 1996/07/01.
doi: 10.1002/jts.2490090305
pubmed: 8827649
Crystal TRichardP, Lawrence C. Posttraumatic growth: Positive changes in the aftermath of crisis. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers, 1998, p.viii, 258-viii, 258.
Carver CS, Antoni MH. Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health Psychol. 2004;23:595–8. https://doi.org/10.1037/0278-6133.23.6.595 . 2004/11/18.
doi: 10.1037/0278-6133.23.6.595
pubmed: 15546227
Ruini C, Vescovelli F, Albieri E. Post-traumatic growth in breast cancer survivors: new insights into its relationships with well-being and distress. J Clin Psychol Med Settings. 2013;20:383–91. 2012/12/12.
doi: 10.1007/s10880-012-9340-1
pubmed: 23229823
Carver CS, Antoni MH. Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health Psychol. 2004;23:595–8. https://doi.org/10.1037/0278-6133.23.6.595 . 2004/11/18.
doi: 10.1037/0278-6133.23.6.595
pubmed: 15546227
Nenova M, DuHamel K, Zemon V, et al. Posttraumatic growth, social support, and social constraint in hematopoietic stem cell transplant survivors. Psycho-oncology. 2013;22:195–202. 2011/10/06.
doi: 10.1002/pon.2073
pubmed: 21972000
Casellas-Grau A, Ochoa C, Ruini C. Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psycho-oncology. 2017;26:2007–18. https://doi.org/10.1002/pon.4426 . 2017/03/21.
doi: 10.1002/pon.4426
pubmed: 28317221
Fox KR, Posluszny DM, DiMartini AF, et al. Predictors of post-traumatic psychological growth in the late years after lung transplantation. Clin Transpl. 2014;28:384–93. 2014/04/23.
doi: 10.1111/ctr.12301
Kruckenberg KM, Shenai N, Dew MA, et al. Transplant-related trauma, personal growth and alcohol use outcomes in a cohort of patients receiving transplants for alcohol associated liver disease. Gen Hosp Psychiatry. 2021;72:73–80. 2021/07/27.
doi: 10.1016/j.genhosppsych.2021.07.005
pubmed: 34311144
Oh JM, Kim Y, Kwak Y. Factors influencing posttraumatic growth in ovarian cancer survivors. Support Care Cancer. 2021;29:2037–45. https://doi.org/10.1007/s00520-020-05704-6 . 2020/08/28.
doi: 10.1007/s00520-020-05704-6
pubmed: 32851485
Widows MR, Jacobsen PB, Booth-Jones M, et al. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol. 2005;24:266–73. https://doi.org/10.1037/0278-6133.24.3.266 . 2005/05/19.
doi: 10.1037/0278-6133.24.3.266
pubmed: 15898862
Perez-San-Gregorio MA, Martin-Rodriguez A, Borda-Mas M, et al. Post-traumatic growth and its relationship to quality of life up to 9 years after liver transplantation: a cross-sectional study in Spain. BMJ Open. 2017;7:e017455. https://doi.org/10.1136/bmjopen-2017-017455 . 2017/09/18.
doi: 10.1136/bmjopen-2017-017455
pubmed: 28918413
pmcid: 5640137
Jeon M, Yoo IY, Kim S, et al. Post-traumatic growth in survivors of allogeneic hematopoietic stem cell transplantation. Psycho-oncology. 2015;24:871–7. 2014/11/11.
doi: 10.1002/pon.3724
pubmed: 25382562
Ramachandran V, Kolli SS, Strowd LC. Review of graft-versus-host disease. Dermatol Clin. 2019;37:569–82. https://doi.org/10.1016/j.det.2019.05.014 . 2019/08/31.
doi: 10.1016/j.det.2019.05.014
pubmed: 31466596
Gifford G, Gilroy N, Dyer G, et al. The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Bone Marrow Transplant. 2016;51:1361–8. 2016/05/24.
doi: 10.1038/bmt.2016.135
pubmed: 27214081
Brice L, Gilroy N, Dyer G, et al. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? Support Care in Cancer. 2017;25:421–7. 2016/10/05.
doi: 10.1007/s00520-016-3418-5
Brice L, McErlean G, Donovan C, et al. Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: a cross-sectional study. Eur J Oncol Nurs. 2020;49:101845. 2020/11/01.
doi: 10.1016/j.ejon.2020.101845
pubmed: 33128994
Dyer G, Brice L, Gilroy N, et al. Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia. Bone Marrow Transplant. 2018;53:926–31. 2018/01/31.
doi: 10.1038/s41409-018-0098-4
pubmed: 29379170
Dyer G, Gilroy N, Brown L, et al. What they want: inclusion of blood and marrow transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia. Biol Blood Marrow Transplant. 2016;22:731–43. 2016/01/10.
doi: 10.1016/j.bbmt.2015.12.019
pubmed: 26746819
Lovibond SH, Lovibond PF. Manual for the Depression anxiety stress scales. 2nd ed. Sydney, Australia: Psychology Foundation of Australia; 1996.
Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer. 1997;80:1936–44. Research Support, U.S. Gov’t, P.H.S. 1997/11/20.
doi: 10.1002/(SICI)1097-0142(19971115)80:10<1936::AID-CNCR10>3.0.CO;2-Z
pubmed: 9366296
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin oncology: official J Am Soc Clin Oncol. 1993;11:570–9. https://doi.org/10.1200/JCO.1993.11.3.570 . Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. 1993/03/01.
doi: 10.1200/JCO.1993.11.3.570
Pavletic SZ, Martin P, Lee SJ et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252–266. Guideline Research Support, N.I.H., Intramural Research Support, U.S. Gov’t, Non-P.H.S. 2006/03/01. DOI: https://doi.org/10.1016/j.bbmt.2006.01.008 .
Lee S, Cook EF, Soiffer R, et al. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2002;8:444–52. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Validation Studies 2002/09/18.
doi: 10.1053/bbmt.2002.v8.pm12234170
pubmed: 12234170
Crawford JR, Henry JD. The Depression anxiety stress scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42:111–31. 2003/06/28.
doi: 10.1348/014466503321903544
pubmed: 12828802
Dahm J, Wong D, Ponsford J. Validity of the Depression anxiety stress Scales in assessing depression and anxiety following traumatic brain injury. J Affect Disord. 2013;151:392–6. https://doi.org/10.1016/j.jad.2013.06.011 .
doi: 10.1016/j.jad.2013.06.011
pubmed: 23830002
Gloster AT, Rhoades HM, Novy D, et al. Psychometric properties of the Depression anxiety and stress Scale-21 in older primary care patients. J Affect Disord. 2008;110:248–59. 2008/02/29.
doi: 10.1016/j.jad.2008.01.023
pubmed: 18304648
pmcid: 2709995
Osman A, Wong JL, Bagge CL, et al. The Depression anxiety stress Scales-21 (DASS-21): further examination of dimensions, scale reliability, and correlates. J Clin Psychol. 2012;68:1322–38. 2012/08/30.
doi: 10.1002/jclp.21908
pubmed: 22930477
McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997;19:357–68. https://doi.org/10.1038/sj.bmt.1700672 . Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. 1997/02/02.
doi: 10.1038/sj.bmt.1700672
pubmed: 9051246
Wu X, Kaminga AC, Dai W, et al. The prevalence of moderate-to-high posttraumatic growth: a systematic review and meta-analysis. J Affect Disord. 2019;243:408–15. 2018/10/01.
doi: 10.1016/j.jad.2018.09.023
pubmed: 30268956
Schwartz JR, Thomas EBK, Juckett MB et al. Predictors of posttraumatic growth among hematopoietic cell transplant recipients. Psychooncology 2022 2022/02/01. DOI: https://doi.org/10.1002/pon.5892 .
Skaczkowski G, Hayman T, Strelan P, et al. Complementary medicine and recovery from cancer: the importance of post-traumatic growth. Eur J Cancer Care (Engl). 2013;22:474–83. 2013/06/05.
doi: 10.1111/ecc.12053
pubmed: 23730795
Tomich PL, Helgeson VS. Posttraumatic growth following cancer: links to quality of life. J Trauma Stress. 2012;25:567–73. 2012/10/18.
doi: 10.1002/jts.21738
pubmed: 23073975
Peck JA. The disproportionate impact of COVID-19 on women relative to men: a conservation of resources perspective. Gend Work Organ. 2021;28:484–97. https://doi.org/10.1111/gwao.12597 .
doi: 10.1111/gwao.12597
Cormio C, Romito F, Giotta F, et al. Post-traumatic growth in the italian experience of long-term disease-free Cancer Survivors. Stress Health. 2015;31:189–96. 2015/08/08.
doi: 10.1002/smi.2545
pubmed: 26251971
Jayawickreme E, Blackie LER. Post-traumatic growth as positive personality change: evidence, controversies and future directions. Eur J Pers. 2014;28:312–31. https://doi.org/10.1002/per.1963 .
doi: 10.1002/per.1963
Jayawickreme E, Infurna FJ, Alajak K, et al. Post-traumatic growth as positive personality change: Challenges, opportunities, and recommendations. J Pers. 2021;89:145–65. https://doi.org/10.1111/jopy.12591 . 2020/09/09.
doi: 10.1111/jopy.12591
pubmed: 32897574
Splevins KA, Cohen K, Joseph S, et al. Vicarious posttraumatic growth among interpreters. Qual Health Res. 2010;20:1705–16. 2010/07/29.
doi: 10.1177/1049732310377457
pubmed: 20663936
Harvey J, Berndt M. Cancer caregiver reports of post-traumatic growth following spousal hematopoietic stem cell transplant. Anxiety Stress Coping. 2021;34:397–410. 2020/11/17.
doi: 10.1080/10615806.2020.1845432
pubmed: 33190518
Menger F, Patterson J, O’Hara J, et al. Research priorities on post-traumatic growth: where next for the benefit of cancer survivors? Psycho-oncology. 2020;29:1968–70. https://doi.org/10.1002/pon.5490 .
doi: 10.1002/pon.5490
pubmed: 32691475